Trial Profile
Phase II/III trial for Nosocomial pneumonia Of AR 101
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 29 Nov 2018
Price :
$35
*
At a glance
- Drugs Panobacumab (Primary)
- Indications Nosocomial pneumonia; Pseudomonal infections
- Focus Therapeutic Use
- 29 Nov 2018 New trial record
- 13 Nov 2018 According to Aridis Pharmaceuticals media release, study is expected to start in 2019.